date of enactment of this Act and the 5 
prior fiscal years; 
(B) for reports in subsequent years, all of 
the information described in subparagraph (A), 
except the reference in subparagraph (A)(ii) to 
Federal funds terminated, in progress, or 
awarded in the 6 prior fiscal years shall be 
treated as reference to such funds in the 2 prior 
fiscal years; 
(C) a status and summary report on the 
National Tick-Borne Disease Surveillance Sys-
tem, including— 
(i) the type of information collected 
and stored in the System; 
(ii) the use, distribution, and avail-
ability of such information, including 
guidelines for such use; and 
(iii) the use and coordination of sur-
veillance and patient information data-
bases; and 
(D) information on agreements, partner-
ships, cooperation, coordination, and data shar-
ing with external entities, such as State and 
local governments, other Federal agencies, 
working groups, and global entities; 
VerDate Sep 11 2014 
23:10 Jan 16, 2019
Jkt 089200
PO 00000
Frm 00036
Fmt 6652
Sfmt 6201
E:\BILLS\H220.IH
H220
pbinns on DSK79D2C42PROD with BILLS
(3) a description of major externally funded re-
search, surveillance, education, or other programs 
and initiatives impacting the management or science 
of tick-borne disease; 
(4) recommendations for addressing research 
gaps in scientific understanding of Lyme disease and 
other tick-borne diseases and disorders and relevant 
to development of effective diagnostic tools and 
treatment protocols for Lyme disease and other tick- 
borne diseases and disorders; 
(5) a description of clinical practice guidelines 
for any tick-borne disease published on the National 
Guideline Clearinghouse; 
(6) recommendations for addressing research 
gaps in tick biology and tick management; 
(7) a description of activities for the promotion 
of public awareness and physician education initia-
tives to improve the knowledge of health care pro-
viders and the public in support of clinical and be-
havioral decision making in relationship to Lyme 
disease and other tick-borne disease; and 
(8) a copy of the most recent annual report 
issued by the Tick-Borne Disease Working Group 
and an assessment of progress in achieving rec-
ommendations of that Working Group. 
VerDate Sep 11 2014 
23:10 Jan 16, 2019
Jkt 089200
PO 00000
Frm 00037
Fmt 6652
Sfmt 6201
E:\BILLS\H220.IH
H220
pbinns on DSK79D2C42PROD with BILLS
(c) BIENNIAL REPORTS OF NIH.—The Secretary 
shall ensure that each biennial report under title III of 
the Public Health Service Act (42 U.S.C. 241 et seq.) or 
each triennial report under section 403 of such Act (42 
U.S.C. 283) includes information on actions undertaken 
by the National Institutes of Health to carry out research 
with respect to Lyme disease and other tick-borne disease. 
SEC. 6. DEFINITIONS. 
In this Act: 
(1) BARTONELLOSIS.—The term ‘‘bartonello-
sis’’ means disease caused by Bartonella infection 
from any vector or source, unless otherwise speci-
fied. 
(2) DISORDER.—The term ‘‘disorder’’ means a 
disorder caused by ticks, but not inducing human in-
fection, such as tick paralysis and Alpha-Gal meat 
allergy. 
(3) OFFICE.—The term ‘‘Office’’ means the Of-
fice of Oversight and Coordination for Tick-Borne 
Diseases established under section 2. 
(4) OTHER FEDERAL AGENCY.—Other Federal 
agency means a Federal Department, agency or of-
fice outside of the U.S. Department of Health and 
Human Services. 
VerDate Sep 11 2014 
23:10 Jan 16, 2019
Jkt 089200
PO 00000
Frm 00038
Fmt 6652
Sfmt 6201
E:\BILLS\H220.IH
H220
pbinns on DSK79D2C42PROD with BILLS
(5) SECRETARY.—The term ‘‘Secretary’’ means 
the Secretary of Health and Human Services. 
(6) TICK-BORNE
DISEASE.—The term ‘‘tick- 
borne disease’’ means a disease that is known to be 
transmitted by ticks in the United States, unless 
otherwise specified, or that may be discovered to be 
transmitted by ticks in the United States. 
(7) TICK-BORNE DISEASE WORKING GROUP.— 
The term ‘‘Tick-Borne Disease Working Group’’ 
means the Tick-Borne Disease Working Group es-
tablished under section 2062 of the 21st Century 
Cures Act (42 U.S.C. 284s). 
Æ 
VerDate Sep 11 2014 
23:10 Jan 16, 2019
Jkt 089200
PO 00000
Frm 00039
Fmt 6652
Sfmt 6301
E:\BILLS\H220.IH
H220
pbinns on DSK79D2C42PROD with BILLS